Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-01-06 @ 2:52 AM
Study NCT ID:
NCT00565058
Status:
COMPLETED
Last Update Posted:
2015-07-27
First Post:
2007-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)
Sponsor:
Aptose Biosciences Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-08
Start Date Type:
None
Primary Completion Date:
2009-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-02
Completion Date Type:
ACTUAL
First Submit Date:
2007-11-27
First Submit QC Date:
None
Study First Post Date:
2007-11-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-06-29
Results First Submit QC Date:
None
Results First Post Date:
2015-07-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-06-29
Last Update Post Date:
2015-07-27
Last Update Post Date Type:
ESTIMATED